Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Nautilus Biotechnology, Inc. (NAUT) had Weighted-Average Shares Outstanding (Diluted) of 126.64M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-14.70M |
|
-- |
|
-- |
|
$16.12M |
|
$-16.12M |
|
$1.43M |
|
$-14.70M |
|
$-14.70M |
|
$-14.70M |
|
$-14.70M |
|
$-14.70M |
|
$-14.70M |
|
$-16.12M |
|
$-14.72M |
|
126.64M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
126.64M |
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$98.83M |
|
$3.63M |
|
$78.95M |
|
$177.78M |
|
$8.34M |
|
-- |
|
$25.02M |
|
$33.36M |
|
$144.41M |
|
$144.41M |
|
$144.41M |
|
127.07M |
|
| Cash Flow Statement Financials | |
$-13.10M |
|
$14.23M |
|
$1.10M |
|
$13.39M |
|
$15.63M |
|
$2.24M |
|
$1.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.85 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-13.61M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.18% |
|
-10.18% |
|
-8.27% |
|
-10.18% |
|
$1.14 |
|
$-0.11 |
|
$-0.10 |
|